SAN CLEMENTE, Calif., Feb. 21, 2017 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its fourth quarter and fiscal year 2016 earnings release and conference call.
The Company will release its fourth quarter and fiscal year 2016 results on Wednesday, March 1st, 2017 at approximately 4:00 p.m. EST (1:00 p.m. PST) and will be conducting a conference call concerning those results at 4:30 p.m. EST (1:30 p.m. PST) on Wednesday, March 1st, 2017. The call can be accessed at (800) 936-9761, international (408) 774-4587, and conference ID 72955804. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors and solutions along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, the company manufactures automated pharmacy compounding systems with workflow technology, closed systems transfer devices for hazardous drugs, disposable blood pressure transducers, advanced sensor catheters, and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.
CONTACT: ICU Medical, Inc. Scott Lamb, Chief Financial Officer (949) 366-2183 ICR, Inc. John Mills, Partner (646) 277-1254


AI Deradicalization Tools: How Chatbots Could Help Combat Violent Extremism Online
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
TSMC Posts Record Q1 2026 Profits Driven by Surging AI Chip Demand
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Meta Is Building an AI Version of Mark Zuckerberg to Interact With Employees
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Baker Hughes Sells Waygate Technologies to Hexagon for $1.45 Billion
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Chinese Cars in Europe: Consumer Trust Is Shifting Fast 



